TABLE 4.
Clinical characteristics of patients before and after treatment (analysed by repeated measures ANOVA)
Before treatment | After treatment (day 3) | After treatment (discharge or death) | ||||||||
Methylprednisolone | Standard care | Methylprednisolone | p-value | Standard care | p-value | Methylprednisolone | p-value | Standard care | p-value | |
Borg score | 7.7±1.7 | 7.1±2.6 | 4.8±2.2 | <0.001* | 6.2±3.4 | 0.154 | 1.7±0.8 | <0.001* | 1.8±1.8 | 0.001* |
SpO2 % | 82.1±5.7 | 83.6±4.7 | 88.1±6.1 | <0.001* | 80.5±8.3 | 0.03* | 92.7±2.6 | <0.001* | 89.0±5.0 | 0.08 |
Systolic blood pressure mmHg | 121.4±15.2 | 124.0±14.6 | 127.6±15.3 | 0.049* | 122.8±20.0 | 0.544 | 126±14.0 | 0.009* | 124.5±35.3 | 0.75 |
Diastolic blood pressure mmHg | 76.1±9.4 | 75.3±7.7 | 78.0±8.8 | 0.28 | 74.0±14.2 | 0.76 | 74.7±9.0 | 0.54 | 74.0±8.2 | 0.33 |
Heart rate beats·min−1 | 93.9±13.2 | 84.6±15.3 | 82.0±11.9 | <0.001* | 84.7±13.8 | 0.78 | 81.2±7.9 | 0.003* | 85.9±17.7 | 0.41 |
Respiratory rate breaths·min−1 | 23.7±4.6 | 21.4±4.5 | 20.8±3.1 | 0.001* | 23.1±5.1 | 0.047* | 18.6±2.4 | <0.001* | 21.0±3.8 | 0.89 |
Body temperature °C | 37.3±0.9 | 37.2±0.8 | 36.7±0.4 | 0.001* | 36.8±0.6 | 0.09 | 36.7±0.4 | 0.008* | 36.8±0.3 | 0.29 |
GI symptoms | 16 (47.1) | 13 (46.4) | 2 (5.9) | <0.001* | 5 (17.9) | 0.18 | 1 (3.1) | <0.001* | 1 (6.3) | 0.014* |
Myalgia | 17 (50.0) | 15 (53.6) | 4 (11.8) | 0.001* | 5 (17.9) | 0.025* | 0 | <0.001* | 1 (6.3) | 0.025* |
Chest pain | 7 (20.6) | 5 (17.9) | 2 (5.9) | 0.025* | 2 (7.1) | 0.16 | 1 (3.1) | 0.014* | 1 (6.3) | 0.32 |
Cough | 23 (67.6) | 16 (57.1) | 12 (35.3) | 0.003* | 12 (42.9) | 0.16 | 6 (18.8) | <0.001* | 6 (37.5) | 0.32 |
Need for oxygen therapy | 34 (100) | 28 (100) | 28 (82.4) | 0.025* | 26 (92.8) | 0.56 | 6 (18.8) | <0.001* | 6 (37.5) | 0.003* |
Data are presented as mean±sd or n (%), unless otherwise stated. SpO2: arterial oxygen saturation measured by pulse oximetry; GI: gastrointestinal; NA: not available. *: p<0.05.